ESSA Pharma to Present at the Jefferies Global Healthcare Conference
ESSA Pharma (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for prostate cancer, announced it will present at the Jefferies Global Healthcare Conference on June 6, 2024, at 12:30 p.m. ET in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ESSA Pharma (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for prostate cancer, announced it will present at the Jefferies Global Healthcare Conference on June 6, 2024, at 12:30 p.m. ET in New York.
Company executives David R. Parkinson (President & CEO) and David S. Wood (CFO) will host and participate in one-on-one meetings.
The event will be webcast live and available on the ESSA website for 90 days.
Positive
- Participation in a high-profile conference can enhance investor interest.
- Opportunity for live engagement with investors and stakeholders via webcast.
- Archived webcast availability extends the reach and impact of the presentation.
Negative
- No new financial or clinical data disclosed in the announcement.
- Potential investor expectations may not be met without substantive news.
- Costs associated with conference participation may impact financials.
Details
News Market Reaction – EPIX
The recorded move for EPIX in the trading session of this news was +4.40%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
David. R. Parkinson, President, and Chief Executive Officer and David S. Wood, Chief Financial Officer, will host and participate in one-on-one meetings.
A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com, and follow us on Twitter and LinkedIn.
ESSA Pharma, Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-jefferies-global-healthcare-conference-302158625.html
SOURCE ESSA Pharma Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.